Champions Oncology, Inc. (NASDAQ:CSBR) Q1 2026 Earnings Call Transcript September 15, 2025
Champions Oncology, Inc. beats earnings expectations. Reported EPS is $0.02, expectations were $-0.01.
Operator: Greetings. Welcome to the Champions Oncology First Quarter Fiscal Year 2026 Earnings Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to your host, Rob Brainin, Chief Executive Officer. You may begin.
Robert Brainin: Good...
